Copyright Reports & Markets. All rights reserved.

Global Amphotericin B Liposome for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Specification
    • 1.3.1 Overview: Global Amphotericin B Liposome for Injection Consumption Value by Specification: 2019 Versus 2023 Versus 2030
    • 1.3.2 2mg
    • 1.3.3 10mg
    • 1.3.4 50mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Amphotericin B Liposome for Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Amphotericin B Liposome for Injection Market Size & Forecast
    • 1.5.1 Global Amphotericin B Liposome for Injection Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Amphotericin B Liposome for Injection Sales Quantity (2019-2030)
    • 1.5.3 Global Amphotericin B Liposome for Injection Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Gilead Sciences
    • 2.1.1 Gilead Sciences Details
    • 2.1.2 Gilead Sciences Major Business
    • 2.1.3 Gilead Sciences Amphotericin B Liposome for Injection Product and Services
    • 2.1.4 Gilead Sciences Amphotericin B Liposome for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Gilead Sciences Recent Developments/Updates
  • 2.2 SPH New Asia Pharmaceuticals
    • 2.2.1 SPH New Asia Pharmaceuticals Details
    • 2.2.2 SPH New Asia Pharmaceuticals Major Business
    • 2.2.3 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product and Services
    • 2.2.4 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 SPH New Asia Pharmaceuticals Recent Developments/Updates
  • 2.3 Jemincare
    • 2.3.1 Jemincare Details
    • 2.3.2 Jemincare Major Business
    • 2.3.3 Jemincare Amphotericin B Liposome for Injection Product and Services
    • 2.3.4 Jemincare Amphotericin B Liposome for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Jemincare Recent Developments/Updates

3 Competitive Environment: Amphotericin B Liposome for Injection by Manufacturer

  • 3.1 Global Amphotericin B Liposome for Injection Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Amphotericin B Liposome for Injection Revenue by Manufacturer (2019-2024)
  • 3.3 Global Amphotericin B Liposome for Injection Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Amphotericin B Liposome for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Amphotericin B Liposome for Injection Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Amphotericin B Liposome for Injection Manufacturer Market Share in 2023
  • 3.5 Amphotericin B Liposome for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Amphotericin B Liposome for Injection Market: Region Footprint
    • 3.5.2 Amphotericin B Liposome for Injection Market: Company Product Type Footprint
    • 3.5.3 Amphotericin B Liposome for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Amphotericin B Liposome for Injection Market Size by Region
    • 4.1.1 Global Amphotericin B Liposome for Injection Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Amphotericin B Liposome for Injection Consumption Value by Region (2019-2030)
    • 4.1.3 Global Amphotericin B Liposome for Injection Average Price by Region (2019-2030)
  • 4.2 North America Amphotericin B Liposome for Injection Consumption Value (2019-2030)
  • 4.3 Europe Amphotericin B Liposome for Injection Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Amphotericin B Liposome for Injection Consumption Value (2019-2030)
  • 4.5 South America Amphotericin B Liposome for Injection Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Amphotericin B Liposome for Injection Consumption Value (2019-2030)

5 Market Segment by Specification

  • 5.1 Global Amphotericin B Liposome for Injection Sales Quantity by Specification (2019-2030)
  • 5.2 Global Amphotericin B Liposome for Injection Consumption Value by Specification (2019-2030)
  • 5.3 Global Amphotericin B Liposome for Injection Average Price by Specification (2019-2030)

6 Market Segment by Application

  • 6.1 Global Amphotericin B Liposome for Injection Sales Quantity by Application (2019-2030)
  • 6.2 Global Amphotericin B Liposome for Injection Consumption Value by Application (2019-2030)
  • 6.3 Global Amphotericin B Liposome for Injection Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Amphotericin B Liposome for Injection Sales Quantity by Specification (2019-2030)
  • 7.2 North America Amphotericin B Liposome for Injection Sales Quantity by Application (2019-2030)
  • 7.3 North America Amphotericin B Liposome for Injection Market Size by Country
    • 7.3.1 North America Amphotericin B Liposome for Injection Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Amphotericin B Liposome for Injection Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Amphotericin B Liposome for Injection Sales Quantity by Specification (2019-2030)
  • 8.2 Europe Amphotericin B Liposome for Injection Sales Quantity by Application (2019-2030)
  • 8.3 Europe Amphotericin B Liposome for Injection Market Size by Country
    • 8.3.1 Europe Amphotericin B Liposome for Injection Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Amphotericin B Liposome for Injection Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Amphotericin B Liposome for Injection Sales Quantity by Specification (2019-2030)
  • 9.2 Asia-Pacific Amphotericin B Liposome for Injection Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Amphotericin B Liposome for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Amphotericin B Liposome for Injection Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Amphotericin B Liposome for Injection Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Amphotericin B Liposome for Injection Sales Quantity by Specification (2019-2030)
  • 10.2 South America Amphotericin B Liposome for Injection Sales Quantity by Application (2019-2030)
  • 10.3 South America Amphotericin B Liposome for Injection Market Size by Country
    • 10.3.1 South America Amphotericin B Liposome for Injection Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Amphotericin B Liposome for Injection Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Amphotericin B Liposome for Injection Sales Quantity by Specification (2019-2030)
  • 11.2 Middle East & Africa Amphotericin B Liposome for Injection Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Amphotericin B Liposome for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Amphotericin B Liposome for Injection Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Amphotericin B Liposome for Injection Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Amphotericin B Liposome for Injection Market Drivers
  • 12.2 Amphotericin B Liposome for Injection Market Restraints
  • 12.3 Amphotericin B Liposome for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Amphotericin B Liposome for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Amphotericin B Liposome for Injection
  • 13.3 Amphotericin B Liposome for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Amphotericin B Liposome for Injection Typical Distributors
  • 14.3 Amphotericin B Liposome for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Amphotericin B Liposome for Injection is a antifungal liposomal formulation. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
    According to our (Global Info Research) latest study, the global Amphotericin B Liposome for Injection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Amphotericin B Liposome for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Specification and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Amphotericin B Liposome for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Amphotericin B Liposome for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Amphotericin B Liposome for Injection market size and forecasts, by Specification and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Amphotericin B Liposome for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Amphotericin B Liposome for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Amphotericin B Liposome for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Amphotericin B Liposome for Injection market is split by Specification and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Specification, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Specification
    2mg
    10mg
    50mg
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Gilead Sciences
    SPH New Asia Pharmaceuticals
    Jemincare
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Amphotericin B Liposome for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Amphotericin B Liposome for Injection, with price, sales quantity, revenue, and global market share of Amphotericin B Liposome for Injection from 2019 to 2024.
    Chapter 3, the Amphotericin B Liposome for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Amphotericin B Liposome for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Specification and by Application, with sales market share and growth rate by Specification, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Amphotericin B Liposome for Injection market forecast, by regions, by Specification, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Amphotericin B Liposome for Injection.
    Chapter 14 and 15, to describe Amphotericin B Liposome for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now